Related Experiment Videos
DNA topoisomerase-trapping antitumour drugs
1Division of Experimental Oncology B, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Improved apoptotic cell death in drug-resistant non-small-cell lung cancer cells by tumor necrosis factor-related apoptosis-inducing ligand-based treatment.
The Journal of pharmacology and experimental therapeutics·2013
Tyrosyl-DNA phosphodiesterase 1 targeting for modulation of camptothecin-based treatment.
Current medicinal chemistry·2010
ABC transporters as potential targets for modulation of drug resistance.
Mini reviews in medicinal chemistry·2009
Small molecules targeting p53 to improve antitumor therapy.
Mini reviews in medicinal chemistry·2008
DNA topoisomerase II structures and anthracycline activity: insights into ternary complex formation.
Current pharmaceutical design·2007
Lenvatinib plus pembrolizumab for the treatment of patients with non-BRAF mutated anaplastic thyroid cancer: A single center, phase 2 clinical trial.
European journal of cancer (Oxford, England : 1990)·2026
Older adults with resectable gastric cancer undergoing perioperative chemotherapy or preoperative chemoradiotherapy plus perioperative chemotherapy: A secondary analysis of the AGITG TOPGEAR phase III trial.
European journal of cancer (Oxford, England : 1990)·2026
Diagnostic regulatory pathways are an underrecognized bottleneck in precision oncology clinical trials: Real-world evidence across Europe.
European journal of cancer (Oxford, England : 1990)·2026
Hypomethylating agents with venetoclax for newly diagnosed acute myeloid leukemia in patients 65 and older in The Netherlands - A nationwide study of drug usage and treatment outcomes.
European journal of cancer (Oxford, England : 1990)·2026
Spectral cytometry-based immune profiling coupled with machine learning identifies circulating Th1-like cells as a blood biomarker for advanced colorectal adenomas.
European journal of cancer (Oxford, England : 1990)·2026
Systemic therapies for gastroenteropancreatic neuroendocrine carcinomas: Current paradigm and future avenues.
European journal of cancer (Oxford, England : 1990)·2026